[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
To boost the quality of each compound, our company has been organized into Business Units since January 2020. This organization also aims to make the Group’s activities clearer for employees, customers, partners and investors. Each BU has its own objectives and resources. They will naturally lead to subsidiaries in the coming years depending on their level of maturity.
Are you a shareholder? You can receive all useful information for your investments directly by e-mail.
"Oncodesign has been listed on Euronext Growth Market since April 2014 (ALONC, Paris). Our biggest goal since our creation has been to discover effective therapies to fight cancer and other diseases for which no treatment is currently available. We have built a unique platform of precision medicine dedicated to resistant or refractory diseases (...)"